FDA 483 - Delcath Systems Inc. - February 15, 2013

An FDA inspection of Delcath Systems Inc. in Queensbury, NY, a combination product manufacturer, revealed significant deficiencies across its quality system. The firm was cited for inadequate design input documentation, insufficient design validation and verification, and failures in process validation. Additionally, issues were noted with statistical techniques, supplier qualification procedures, and the maintenance of device master records.